Monthly Archives: March 2008

Toshiba launches Breakthrough CT System – the Aquilion ONE

March 31st, 2008|

Toshiba America Medical Systems, Inc launches the first Dynamic Volume Computed Tomography System Enables Faster which is more Accurate Diagnosis to reduce healthcare costs and improve patient care.

Teva to buy Bentley Pharma for $360M

March 31st, 2008|

Teva Pharmaceutical Industries Ltd. will pay $360 million in cash for Bentley Pharmaceuticals Inc. in a move to expand operations in Spain.

Sun Pharma launches cancer drug, Ethyol

March 31st, 2008|

Sun Pharmaceutical Industries  has commercially launched generic Ethyol, used in the treatment of cancer.

Siemens plans to Launch PETNET Services in India

March 31st, 2008|

Siemens Healthcare plans to launch its first molecular imaging biomarker production facility in Chennai, India.

Boston Scientific receives European Approval of new heart failure lead

March 31st, 2008|

Boston Scientific Corporation has received CE Mark approval of its ACUITY® Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, both of which treat heart failure.

BioAlliance Pharma expands its LoramycTM Franchise

March 31st, 2008|

BioAlliance Pharma expands its LoramycTM Franchise by signing a South East Asia deal worth up to $12 Million with the leading Korean Pharma Company Ha

Healthcare initiatives

March 29th, 2008|

India has both substantial achievements as well as a daunting unfinished agenda in the health sector. The National Rural Health Mission is an attempt at building a sustainable health system for the country.   It attempts to address long standing ailments of the health system.

New ways to store information via DNA discovered

March 26th, 2008|

Researchers at the University of California have discovered a new system to encode digital information within DNA. According to the researchers, this method relies on length of the fragments obtained by the partial restriction digest rather than the actual content of nucleotide sequence, a medical journal has reported.

Waters signs agreement tissue imaging research

March 24th, 2008|

Waters Corporation and Vanderbilt University Medical Centre have entered into a collaborative research initiative using the former's Maldi Synapt High Definition MS (HDMS) System for enhanced tissue imaging capabilities in oncology research within the University's Mass Spectrometry Research Centre.

US scientists develop cloned cells to repair damage tissues by Parkinson

March 24th, 2008|

Good news for those suffering from Parkison's disease,  which robs people, the people of the ability to walk and even eat. Reasearchers of Memorial Sloan-Kettering Cancer Centre in the US have cloned cells that can repair the damage in tissues caused by Parkison's disease.

Ayurveda, medicine to get boost : ASSOCHAM

March 24th, 2008|

Ayurvedic and medical tourism is likely to be the largest beneficiary of 2010 Commonwealth Games and may gain by around Rs 800 crores. The revenue generation for ayuvedic industry will be mainly driven through spa centres, which means pampering exterior of those tourists that stay in various hotels, beginning five star to one star.

Sun Pharmaceutical receives USFDA approval to market generic Tessalon®

March 24th, 2008|

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted approval for the Abbreviated New Drug Application (ANDA) to market a generic version of Forest Lab’s Tessalon®, benzonatate capsules.

DST and Mediclone Biotech to develop rabies infection drug

March 24th, 2008|

Department of Science and Technology (DST), Government of India and Chennai-based Mediclone Biotech Pvt. Ltd have entered into a collaboration under which a new drug will be developed at Mediclone Biotech for dog bite victims to avoid rabies infection.

US Seeks Harmonization of Regulatory Structures to improve healthcare

March 20th, 2008|

The US is seeking additional scientific, regulatory and technical collaboration with India as a means to improve healthcare outcomes for patients around the world said Honorable Michael O. Leavitt, Secretary, U.S. Department of Health and Human Services said at a meeting hosted by U.S.-India Business Council (USIBC).  Sharing his observations from his recent visit to India with Industry leaders, he recommended collaboration as a means to improve healthcare outcomes for patients around the world.

Sun Pharmaceutical gets USFDA approval to market Cerebyx®

March 19th, 2008|

Sun Pharmaceutical Industries Ltd. has received approval from  for the Abbreviated New Drug Application (ANDA) to market a generic version of Parke Davis’s Cerebyx®, fosphenytoin sodium injection.

US FDA licenses Daptacel vaccine

March 17th, 2008|

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, has received licenses  from the US Food and Drug Administration (FDA) to administered Daptacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) as a fifth consecutive diphtheria, tetanus, and acellular pertussis (DTaP) vaccine dose.

Sun Pharmaceutical receives USFDA approval to market generic Ethyol®

March 17th, 2008|

Sun Pharmaceutical Industries Ltd. has received USFDA approval for the Abbreviated New Drug Application (ANDA) to market a generic version of MedImmune’s Ethyol®, amifostine for injection 500mg.

Strides Arcolab receives Health Canada approval for Tazo Pip Injection

March 17th, 2008|

Strides Arcolab, one of India’s largest exporters of branded generic pharmaceutical products, has received its second ANDS approval from Health Canada for Tazo Pip Sterile Injection in three presentations.

Rationalization of rate of duty on pharma products

March 17th, 2008|

Pharma units are eligible for general small-scale industries excise duty exemption scheme. As such, units having clearance value upto Rs 4 crore in the preceding financial year are eligible for full excise duty exemption on their first clearances upto Rs 1.5 crore in a financial year, subject to certain conditions.

ONCO Life signs pact for business development of chemiluminometer

March 17th, 2008|

ONCO Life Sciences, the Pune-based pharmaceutical consulting and marketing company, has entered into a tie up with the Berlin-based Research Institute for Antioxidative Therapy (FAT GmbH) to work as an exclusive business developer for its solution systems in the global market.